TY - JOUR
T1 - Vanishing Bile Duct Syndrome Caused by a Treatment Regimen Including Avacopan for Microscopic Polyangiitis
AU - Hishinuma, Mako
AU - Hasegawa, Midori
AU - Minatoguchi, Shun
AU - Umeda, Ryosuke
AU - Koide, Shigehisa
AU - Hayashi, Hiroki
AU - Yuzawa, Yukio
AU - Minamiguchi, Sachiko
AU - Tsuboi, Naotake
N1 - Publisher Copyright:
© 2026 The Japanese Society of Internal Medicine.
PY - 2026
Y1 - 2026
N2 - An 81-year-old man was treated with prednisolone, avacopan, and rituximab for microscopic polyangiitis and sulfamethoxazole/trimethoprim (SMX/TMP) and vonoprazan for prophylaxis. The liver enzyme levels were elevated 42 days after avacopan administration. Avacopan, SMX/TMP, and vonoprazan treatment were discontinued. A liver biopsy revealed vanishing bile duct syndrome. The patient was subsequently treated with ursodeoxycholic acid and glucocorticoid. Although vasculitis remained in remission, the patient ultimately died. Autopsy revealed persistent bile ductopenia and progressive liver cell injury confirmed by cytokeratin 7 positivity, severe cholestasis, and portal fibrosis. Further studies are required to elucidate associated mechanisms and risk factors.
AB - An 81-year-old man was treated with prednisolone, avacopan, and rituximab for microscopic polyangiitis and sulfamethoxazole/trimethoprim (SMX/TMP) and vonoprazan for prophylaxis. The liver enzyme levels were elevated 42 days after avacopan administration. Avacopan, SMX/TMP, and vonoprazan treatment were discontinued. A liver biopsy revealed vanishing bile duct syndrome. The patient was subsequently treated with ursodeoxycholic acid and glucocorticoid. Although vasculitis remained in remission, the patient ultimately died. Autopsy revealed persistent bile ductopenia and progressive liver cell injury confirmed by cytokeratin 7 positivity, severe cholestasis, and portal fibrosis. Further studies are required to elucidate associated mechanisms and risk factors.
KW - avacopan
KW - liver injury
KW - microscopy polyangiitis
UR - https://www.scopus.com/pages/publications/105034798534
UR - https://www.scopus.com/pages/publications/105034798534#tab=citedBy
U2 - 10.2169/internalmedicine.5043-24
DO - 10.2169/internalmedicine.5043-24
M3 - Article
C2 - 40930823
AN - SCOPUS:105034798534
SN - 0918-2918
VL - 65
SP - 1017
EP - 1022
JO - Internal Medicine
JF - Internal Medicine
IS - 7
ER -